Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
暂无分享,去创建一个
Alfonso Valencia | Manuel Hidalgo | Samuel V. Angiuoli | David Sidransky | Samuel V Angiuoli | Elena Garralda | A. Valencia | V. Velculescu | Siân Jones | L. Diaz | M. Hidalgo | L. Kann | F. Al-Shahrour | F. López-Ríos | D. Sidransky | P. López-Casas | A. Katz | E. Bruckheimer | K. Paz | Victor E Velculescu | Siân Jones | E. Garralda | P. Lopez-Casas | F. López-Ríos | Francesca Sarno | F. Al-Shahrour | David Vasquez | A. Calles | Luis A Diaz | Keren Paz | Pedro P López-Casas | Amanda Katz | Lisa M Kann | Fernando López-Rios | Francesca Sarno | Fátima Al-Shahrour | David Vasquez | Elizabeth Bruckheimer | Antonio Calles | F. López-Rios
[1] T. MacDonald,et al. A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low‐grade glioma (LGG) , 2013, Pediatric blood & cancer.
[2] Y. Iwamoto,et al. Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors , 2012, Clinical Cancer Research.
[3] S. Kopetz,et al. The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men , 2012, Clinical Cancer Research.
[4] A. Valencia,et al. Getting personalized cancer genome analysis into the clinic: the challenges in bioinformatics , 2012, Genome Medicine.
[5] Michael R. Hayden,et al. Whole-Genome Sequencing: The New Standard of Care? , 2012, Science.
[6] Shengyue Wang,et al. Exploring the cancer genome in the era of next-generation sequencing , 2012, Frontiers of Medicine.
[7] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[8] M. Baker. Functional genomics: The changes that count , 2012, Nature.
[9] T. Hudson,et al. The Genetic Basis for Cancer Treatment Decisions , 2012, Cell.
[10] M. Hidalgo,et al. Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] David R Parkinson,et al. Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics , 2012, Clinical Cancer Research.
[12] C. Corless. Personalized Cancer Diagnostics , 2011, Science.
[13] M. Hidalgo,et al. A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer , 2011, Molecular Cancer Therapeutics.
[14] M. Meyerson,et al. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. , 2011, Cancer discovery.
[15] M. Stratton. Exploring the Genomes of Cancer Cells: Progress and Promise , 2011, Science.
[16] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[17] I. Nagtegaal,et al. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients , 2011, British Journal of Cancer.
[18] L. Garraway,et al. Clinical implications of the cancer genome. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Manuel Hidalgo,et al. Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer , 2010, Molecular Cancer Therapeutics.
[20] Michael Bittner,et al. Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] L. Ellis,et al. Finding the tumor copycat: Therapy fails, patients don't , 2010, Nature Medicine.
[22] J. Salk. Clonal evolution in cancer , 2010 .
[23] M. Fujii,et al. G-protein γ subunit GNG11 strongly regulates cellular senescence , 2006 .
[24] R. Hruban,et al. An In vivo Platform for Translational Drug Development in Pancreatic Cancer , 2006, Clinical Cancer Research.
[25] M. Fujii,et al. G-protein gamma subunit GNG11 strongly regulates cellular senescence. , 2006, Biochemical and biophysical research communications.